Public Release: 

Future of Genomic Medicine V conference set for March 1-2 in San Diego

Cancer genomics, stem cells and pediatric medicine among topics to be discussed

Scripps Health

SAN DIEGO (Jan. 18, 2012) - Scripps Translational Science Institute (STSI) will present its fifth annual educational conference exploring the latest achievements and challenges in the use of genomics to diagnose and treat disease and medical conditions on March 1-2, 2012, in San Diego.

The conference, The Future of Genomic Medicine V, will offer a dynamic, interactive forum where human geneticists, genomic scientists, physicians and health-care professionals of all disciplines can gain valuable insights from many of the nation's leading genomics experts.

The opening session will feature Noah and Alexis Beery, teenage twins who were successfully treated for a rare genetic disorder only when their entire genomes were sequenced after years of baffling symptoms and misdiagnosis. Their story illustrates how genomics is transforming the practice of medicine.

Other sessions will include an update on the Wellderly Study, which is examining the DNA of healthy elderly people to discover the genetic secrets to long life spans, as well as an overview of the confluence of genomics and medicine by Matthew Herper, a senior editor at Forbes magazine and author of The Medicine Show blog.

The program will include more than 30 specialized presentations interspersed with panel discussions and question-and-answer sessions. The March 1 schedule will focus on the emerging role of genetic testing in the diagnosis and treatment of diseases. Presentations on March 2 will cover a wide range of topics including cancer genomics, stem cells and the disruptive power of genomics in the field of medicine.

The conference is led by course director Eric J. Topol, M.D, chief academic officer of Scripps Health and director of STSI. His book, "The Creative Destruction of Medicine," will be released in hardback on Feb. 1. The program will take place at the Scripps Seaside Forum, located at 8610 Kennel Way, La Jolla, Calif., 92037.

Registration for the conference is $95 and is complimentary for all students, residents and fellows. Pre-registration will be accepted through Feb. 16, 2012, on a space-available basis. More information is available at or by calling Scripps Conference Services & CME at 858-652-5400.



Part of San Diego, Calif.-based Scripps Health, the Scripps Translational Science Institute (STSI) is a unique community collaboration that initiates research that moves basic science from the lab to the patient bedside. STSI is supported by the NIH flagship program, Clinical and Translational Science Award (CTSA). Collaborators in the STSI consortium include Scripps Health; The Scripps Research Institute; the Burnham Institute for Medical Research; Children's Hospital of Philadelphia; Genomics Institute of the Novartis Research Foundation; The J. Craig Venter Institute; Salk Institute for Biological Studies; San Diego State University; San Diego Supercomputer Center; and The Neurosciences Institute.


Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a $2.45 billion nonprofit integrated health system based in San Diego, Calif. Scripps treats a half-million patients annually through the dedication of 2,600 affiliated physicians and 13,000 employees among its five acute-care hospital campuses, home health care services, and an ambulatory care network of physician offices and 23 outpatient centers and clinics.

Recognized as a leader in the prevention, diagnosis, and treatment of disease, Scripps is also at the forefront of clinical research, genomic medicine, wireless health care and graduate medical education. With three highly respected graduate medical education programs, Scripps is a longstanding member of the Association of American Medical Colleges. More information can be found at

Contact: Keith Darce
Phone: 858-678-7121
Cell: 858-336-9069

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.